Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Trials & Approvals

Updates on new clinical tirals being performed in China, trial updates and drug approvals...

Adlai Nortye Starts Phase III Trial of Pan- PI3K Inhibitor in Head and Neck Carcinoma

Kintor Starts China Trials of Topical Androgen Receptor Inhibitor

Innovent Reports Positive Data from Phase III Tyvyt Trial in NSCLC

LintonPharm Starts China Trial of Candidate for Bladder Cancer

Junshi's PD-1 Approved for Third Indication in China, Bladder Cancer

Upcoming event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
The Ritz-Carlton Shanghai Pudong
March 23-25, 2021